Effects of Stobadine and Vitamin E in Diabetes-Induced Retinal Abnormalities: Involvement of Oxidative Stress

Archives of Medical Research

Volumn 38, Issue 5, 2007, Pages 503-511

  Yülek, Fatma ^a   Or, Meral ^a   Özoǧul, Candan ^a   Isik, Asli Ceylan ^b   Ari, Nuray ^b   Stefek, Milan ^c   Bauer, Victor ^c   Karasu, Cimen ^a  

^a GAZI UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

^c INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

Aldose reductase; Diabetic rat; Lipid peroxidation; Retina; Stobadine; VEGF; Vitamin E

Indexed keywords

ALDEHYDE REDUCTASE; ALPHA TOCOPHEROL; FRUCTOSAMINE; HEMOGLOBIN A1C; MALONALDEHYDE; STOBADINE; STREPTOZOCIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY BASEMENT MEMBRANE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DRUG EFFECT; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HISTOPATHOLOGY; IMMUNOREACTIVITY; LIPID PEROXIDATION; MALE; MONOTHERAPY; NONHUMAN; OXIDATIVE STRESS; RAT;

ALDEHYDE REDUCTASE; ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; CARBOLINES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ENDOTHELIAL GROWTH FACTORS; IMMUNOHISTOCHEMISTRY; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; RETINA; VITAMIN E;

EID: 34249990014     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2007.02.006     Document Type: Article

References (47)

1. Merimee T.J. Diabetic retinopathy: a synthesis of perspectives. N Engl J Med 322 (1990) 978-983
2. Aiello L.P., Gardner T.W., King G.L., Blankenship G., Cavallerano J.D., Ferris III F.L., et al. Diabetic retinopathy (technical review). Diabetes Care 21 (1998) 143-156
3. Kowluru R.A. Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes 52 (2003) 818-823
4. Comer G.M., and Ciulla T.A. Pharmacotherapy for diabetic retinopathy. Curr Opin Ophthalmol 15 (2004) 508-518
5. Armstrong D., Abdella N., Salman A., Miller N., Rahman E.A., and Bojancyzk M. Relationship of lipid peroxides to diabetic complications. J Diabetes Complications 6 (1992) 116-122
6. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 40 (1991) 405-412
7. Caldwell R.B., Bartoli M., Behzadian M.A., El-Remessy A.E., Al-Shabrawey M., Platt D.H., et al. Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. Curr Drug Targets 6 (2005) 511-524
8. Chung S.S., and Chung S.K. Aldose reductase in diabetic microvascular complications. Curr Drug Targets 6 (2005) 475-486
9. Curtis T.M., and Scholfield C.N. The role of lipids and protein kinase Cs in the pathogenesis of diabetic retinopathy. Diabetes Metab Res Rev 20 (2004) 28-43
10. Stitt A.W., and Curtis T.M. Advanced glycation and retinal pathology during diabetes. Pharmacol Rep 57 suppl (2005) 156-168
11. El-Remessy A.B., Abou-Mohamed G., Caldwell R.W., and Caldwell R.B. High glucose-induced tyrosine nitration in endothelial cells: role of eNOS uncoupling and aldose reductase activation. Invest Ophthalmol Vis Sci 44 (2003) 3135-3143
12. Kato N., Yashima S., Suzuki T., Nakayama Y., and Jomori T. Long-term treatment with fidarestat suppresses the development of diabetic retinopathy in STZ-induced diabetic rats. J Diabetes Complications 17 (2003) 374-379
13. Obrosova I.G., Minchenko A.G., Vasupuram R., White L., Abatan O.I., Kumagai A.K., et al. Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats. Diabetes 52 (2003) 864-871
14. Obrosova I.G., Pacher P., Szabo C., Zsengeller Z., Hirooka H., Stevens M.J., et al. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications. Diabetes 54 (2005) 234-242
15. Cheung A.K., Fung M.K., Lo A.C., Lam T.T., So K.F., Chung S.S., et al. Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. Diabetes 54 (2005) 3119-3125
16. Grant M.B., Afzal A., Spoerri P., Pan H., Shaw L.C., and Mames R.N. The role of growth factors in the pathogenesis of diabetic retinopathy. Expert Opin Investig Drugs 13 (2004) 1275-1293
17. Aiello L.P. Clinical implications of vascular growth factors in proliferative retinopathies. Curr Opin Ophthalmol 8 (1997) 19-31
18. Mayer-Davis E.J., Bell R.A., Reboussin B.A., Rushing J., Marshall J.A., and Hamman R.F. Antioxidant nutrient intake and diabetic retinopathy: the San Luis Valley Diabetes Study. Ophthalmology 105 (1998) 2264-2270
19. Kowluru R.A., Tang J., and Kern T.S. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 50 (2001) 1938-1942
20. Kowluru R.A., and Koppolu P. Diabetes-induced activation of caspase-3 in retina: effect of antioxidant therapy. Free Radic Res 36 (2002) 993-999
21. Kowluru R.A., Koppolu P., Chakrabarti S., and Chen S. Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Radic Res 37 (2003) 1169-1180
22. Di Leo M.A., Ghirlanda G., Gentiloni Silveri N., Giardina B., Franconi F., and Santini S.A. Potential therapeutic effect of antioxidants in experimental diabetic retina: a comparison between chronic taurine and vitamin E plus selenium supplementations. Free Radic Res 37 (2003) 323-330
23. Lin J., Bierhaus A., Bugert P., Dietrich N., Feng Y., Vom Hagen F., et al. Effect of R-(+)-alpha-lipoic acid on experimental diabetic retinopathy. Diabetologia 49 (2006) 1089-1096
24. Yatoh S., Mizutani M., Yokoo T., Kozawa T., Sone H., Toyoshima H., et al. Antioxidants and an inhibitor of advanced glycation ameliorate death of retinal microvascular cells in diabetic retinopathy. Diabetes Metab Res Rev 22 (2006) 38-45
25. Hoffmann J., Alt A., Lin J., Lochnit G., Schubert U., Schleicher E., et al. Tenilsetam prevents early diabetic retinopathy without correcting pericyte loss. Thromb Haemost 95 (2006) 689-695
26. SanGiovanni J.P., and Chew E.Y. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res 24 (2005) 87-138
27. Yamagishi S.I., Matsui T., Nakamura K., Yoshida T., Takeuchi M., Inoue H., et al. Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats. Ophthalmic Res 39 (2007) 92-97
28. Garay R.P., Hannaert P., and Chiavaroli C. Calcium dobesilate in the treatment of diabetic retinopathy. Treat Endocrinol 4 (2005) 221-322
29. Horakova L., and Stolc S. Antioxidant and pharmacodynamic effects of pyridoindole stobadine. Gen Pharmacol 30 (1998) 627-638
30. Stolc S., Vlkolinsky R., and Pavlasek J. Neuroprotection by the pyridoindole stobadine: a minireview. Brain Res Bull 42 (1997) 335-340
31. +2-ATPase activity in heart and liver of streptozotocin-diabetic rats: comparison with vitamin E. Biochim Biophys Acta 1588 (2002) 71-78
32. Ulusu N.N., Sahilli M., Avci A., Canbolat O., Ozansoy G., Ari N., et al. Pentose phosphate pathway, glutathione-dependent enzymes and antioxidant defense during oxidative stress in diabetic rodent brain and peripheral organs: effects of stobadine and vitamin E. Neurochem Res 28 (2003) 815-823
33. Ito M., Miura J., Ito M., Umesato F., Yasuda K., and Takata Y. Correlative retention time peak identification method for glycated haemoglobin in high-performance liquid chromatography. J Chromatogr A 661 (1994) 143-151
34. Jain S.K., and Levine S.N. Elevated lipid peroxidation and vitamin E-quinone levels in heart ventricles of streptozotocin-treated diabetic rats. Free Radic Biol Med 18 (1995) 337-341
35. Das B., and Skrivastava S.K. Purification and properties of aldose reductase and aldehyde reductase II from human erythrocyte. Arch Biochem Biophys 238 (1985) 670-679
36. Robison W.G., Jacot J.L., Katz M.L., and Glover J.P. Retinal vascular changes induced by the oxidative stress of alpha-tocopherol deficiency contrasted with diabetic microangiopathy. J Ocul Pharmacol Ther 16 (2000) 109-120
37. Gunes A., Ceylan A., Sarioglu Y., Stefek M., Bauer V., and Karasu C. The Antioxidants in Diabetes-Induced Complications (ADIC) Study Group. Reactive oxygen species mediate abnormal contractile response to sympathetic nerve stimulation and noradrenaline in the vas deferens of chronically diabetic rats: effects of in vivo treatment with antioxidants. Fundam Clin Pharmacol 19 (2005) 73-79
38. Demiryurek A.T., Karasu C., Stefek M., and Stolc S. Effect of stobadine on leukocyte free radical generation in streptozotocin-diabetic rats: comparison with vitamin E. Pharmacology 70 (2004) 1-4
39. Kuroki M., Voest E.E., Amano S., Beerepoot L.V., Takashima S., Tolentino M., et al. Reactive oxygen intermediates increase vascular endothelial factor expression in vitro and in vivo. J Clin Invest 98 (1996) 1667-1675
40. Frank R.N., Amin R., Kennedy A., and Hohman T.C. An aldose reductase inhibitor and aminoguanidine prevent VEGF expression in rats with long-term galactosemia. Arch Ophthalmol 115 (1997) 1036-1047
41. Obrosova I.G., Minchenko A.G., Marinescu V., Fathallah L., Kennedy A., Stockert C.M., et al. Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats. Diabetologia 44 (2001) 1102-1110
42. Karasu C., Ozansoy G., Bozkurt O., Erdogan D., and Omeroglu S. Antioxidant and triglyceride-lowering effects of vitamin E associated with the prevention of abnormalities in the reactivity and morphology of aorta from streptozotocin-diabetic rats. Antioxidants in Diabetes-Induced Complications (ADIC) Study Group. Metabolism 46 (1997) 872-879
43. Kyselova Z., Gajdosik A., Gajdosikova A., Ulicna O., Mihalova D., Karasu C., et al. Effect of the pyridoindole antioxidant stobadine on development of experimental diabetic cataract and on lens protein oxidation in rats: comparison with vitamin E and BHT. Mol Vis 11 (2005) 56-65
44. Stefek M., Kyselova Z., Rackova L., and Krizanova L. Oxidative modification of rat eye lens proteins by peroxyl radicals in vitro: protection by the chain-breaking antioxidants stobadine and Trolox. Biochim Biophys Acta 741 (2005) 183-190
45. Naziroglu M., and Cay M. Protective role of intraperitoneally administered vitamin E and selenium on the antioxidative defense mechanisms in rats with diabetes induced by streptozotocin. Biol Trace Elem Res 79 (2001) 149-159
46. Steenken S., Sundquist A.R., Jovanovic S.V., Crockett R., and Sies H. Antioxidant activity of the pyridoindole stobadine. Pulse radiolytic characterization of one-electron-oxidized stobadine and quenching of singlet molecular oxygen. Chem Res Toxicol 5 (1992) 355-360
47. Kagan V.E., Tsuchiya M., Serbinova E., Packer L., and Sies H. Interaction of the pyridoindole stobadine with peroxyl, superoxide and chromanoxyl radicals. Biochem Pharmacol 45 (1992) 393-400